Cytomegalovirus-induced CD13-specific autoimmunity - A possible cause of chronic graft-versus-host disease

Transplantation

Volumn 61, Issue 4, 1996, Pages 600-609

  Söderberg, Cecilia ^a,b,c   Larsson, Susanne ^b,c   Rozell, Barbro Lundh ^a   Sumitran Karuppan, Suchitra ^b   Ljungman, Per ^a   Möller, Erna ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Center for BioTechnology

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICROSOMAL AMINOPEPTIDASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; COMPLICATION; CYTOMEGALOVIRUS INFECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SKIN BIOPSY;

3T3 CELLS; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, CD13; AUTOANTIBODIES; AUTOIMMUNITY; BIOPSY; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTIONS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULIN M; MICE; MOUTH MUCOSA; SKIN;

EID: 0029963299     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00015     Document Type: Article

References (40)

1. Lönnqvist B, Ringdén O, Wahren B, Gahrton G, Lundgren G. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 1984; 38: 465.
2. Gratama JW, Fibbe WE, Naipal AM, et al. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease. Bone Marrow Transplant 1986; 1: 141.
3. Jacobsen N, Andersen HK, Skinhoj P, et al. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Scand J Haematol 1986; 36: 499.
4. Boström L, Ringdén O, Jacobsen N, Zwaan F, Nilsson B. A European multicenter study of chronic graft-versus-host disease: the role of cytomegalovirus serology in recipients and donors - acute graft-versus-host disease, and splenectomy. Transplantation 1990; 49: 1100.
5. Saurat JH, Didier-Jean L, Gluckman E, Bussel A. Graft versus host reaction and lichen planus-like eruption in man. Br J Dermatol 1975; 92: 591.
6. Tazzari PL, Gobbi M, Zauli D, et al. Close association between antibodies to cytoskeletal intermediate filaments, and chronic graft-versus-host disease. Transplantation 1987; 44: 234.
7. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Y-antigen killing by T cells of women is restricted by HLA. Nature 1977; 26: 544.
8. Goulmy E, Gratama JW, Blokland E, Zwaan FE, van Rood JJ. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 1983; 302: 159.
9. Pfeffer PF, Thorsby E. HLA-restricted cytotoxicity against male-specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney: clonal distribution of the cytotoxic cells. Transplantation 1982; 33: 52.
10. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974; 248: 701.
11. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986; 44: 959.
12. Kappler JW, Staerz U, White J, Marrack PC. Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature 1988; 332: 35.
13. Söderberg C, Larsson S, Bergstedt-Lindqvist S, Möller E. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol 1993; 67: 3166.
14. Semenza G. Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli. Annu Rev Cell Biol 1986; 2: 255.
15. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989; 83: 1299.
16. Söderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Möller E. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993; 67: 6576.
17. Ringdén O, Klaesson S, Sundberg B, Ljungman P, Lönnqvist B, Persson U. Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings. Bone Marrow Transplant 1992; 9: 19.
18. Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895.
19. Deeg HJ, Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med 1984; 35: 11.
20. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204.
21. Ehrnst A, Barkholt L, Lewensohn-Fuchs I, et al. CMV PCR monitoring in leukocytes of transplant patients. Clin Diagn Virol 1995 3: 139.
22. Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin SA, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Elsevier, 1993: 233.
23. Karuppan SS, Lindholm A, Möller E. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching. Transplantation 1992; 53: 666.
24. Weigert C. Zbl. allg. Path. path. Anat. 1898; 9: 289.
25. Alford CA, Britt WJ. Cytomegalovirus. In: Fields BN, Knipe DM, et al. eds. Virology. New York: Raven, 1990: 1981.
26. Karuppan S, Lindholm A, Möller E. Pre- and post-transplant sensitization in cyclosporin A-treated patients. Clin Transplant 1988 2: 245.
27. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 26124: 3561.
28. Melnick JL, Adam E, De Bakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA 1990; 263: 2204.
29. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391.
30. Hammarström L, Smith E, Primi D, Möller G. Induction of autoantibodies to red blood cells by polyclonal B-cell activators. Nature 1976; 263: 60.
31. Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497.
32. Atkinson K. Pathogenesis of human chronic graft-vs.-host disease. In: Burakoff S, Ferrara J, Deeg H, Atkinson K, eds. Graft-vs.-host disease, vol 12. New York: Dekker, 1990: 615.
33. Atkinson K. Risk factors for and prevention of human chronic graft-vs.-host disease. In: Burakoff S, Ferrara J, Deeg H, Atkinson K, eds. Graft-vs.-host isease, vol 12. New York: Dekker, 1990: 625.
34. Shulman H. Pathology of chronic graft-vs.-host disease. In: Burakoff S, Ferrara J, Deeg H, Atkinson K, eds. Graft-vs.-host disease, vol 12. New York: Dekker, 1990: 587.
35. Gleichmann E, Gleichmann H, Wilke W. Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens? Transplant Rev 1976; 31: 156.
36. Datta SK, Schwartz RS. Autoimmunization and graft versus host reactions. Transplant Rev 1976; 31: 44.
37. Saurat JH, Didierjean L, Beucher F, Gluckman E. Immunofluorescent tracing of cytoplasmic components involved in keratinocyte differentiation. Br J Dermatol 1978; 98: 155.
38. Tsoi MS, Storb R, Jones E, et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol 1978; 120: 1485.
39. Saurat J, Gluckman E, Bonnetblanc J, Didierjean L, AB, AP. Charactères cliniques et biologiques des éruptions licheniennes après greffe de moelle osseuse. Ann Dermatol Syphylig 1975; 102: 521.
40. Lortan JE, Rochfort NC, el-Tumi M, Vellodi A. Autoantibodies after bone marrow transplantation in children with genetic disorders: relation to chronic graft-versus-host disease. Bone Marrow Transplant 1992; 9: 325.